Horst F Schran

Title: Horst F Schran: Innovator in Medicinal Chemistry

Introduction

Horst F Schran is a notable inventor based in Morristown, NJ (US). He has made significant contributions to the field of medicinal chemistry, particularly in the treatment of bone metabolism diseases. With a total of 2 patents, Schran's work has had a meaningful impact on pharmaceutical advancements.

Latest Patents

Schran's latest patents include innovative methods for administering bisphosphonates and combinations of antidiarrheal agents with epothilone derivatives. One of his patents details the use of zolendronate for the manufacture of a medicament aimed at treating bone metabolism diseases. This method involves intravenously administering 4 mg of zoledronic acid over a period of 15 minutes to patients in need of treatment. Another patent focuses on the co-administration of epothilone derivatives with antidiarrheal agents, such as DPP-IV inhibitors, for the treatment of proliferative diseases.

Career Highlights

Throughout his career, Schran has worked with prominent companies in the pharmaceutical industry, including Novartis Pharmaceuticals Corporation and Novartis AG. His experience in these organizations has allowed him to develop and refine his innovative approaches to drug formulation and delivery.

Collaborations

Some of Schran's notable coworkers include Bruno Galli and John J Seaman. Their collaborative efforts have contributed to the advancement of medicinal chemistry and the development of effective treatment options.

Conclusion

Horst F Schran's contributions to medicinal chemistry and his innovative patents demonstrate his commitment to improving healthcare through scientific advancements. His work continues to influence the pharmaceutical industry and offers hope for patients with bone metabolism diseases.